Title : Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.

Pub. Date : 2015 Mar

PMID : 25701170






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial. orteronel proprotein convertase subtilisin/kexin type 4 Homo sapiens